+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 19Years +
All Genders
ID07314073

Phase 2 Study of 18F-Fluoroestradiol PETCT to Detect Distant Metastases in Low-grade Estrogen Receptor-positive Stage III Breast Cancer

Led by Asan Medical Center · Updated on 2026-01-02

85

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of 18F-fluoroestradiol 18F-FES PETCT imaging to detect distant metastases in patients with low-grade, estrogen receptor-positive stage III breast cancer. This study focuses on improving detection in this subgroup where current imaging methods like 18F-FDG PETCT have limitations, especially in invasive lobular carcinoma and low-grade tumors. The trial aims to better understand the accuracy and clinical impact of 18F-FES PETCT in this setting. Participants will undergo 18F-FES PETCT scans to visualize estrogen receptor expression and detect metastatic disease. The study will compare 18F-FES PETCT results to standard imaging methods, including 18F-FDG PETCT, CT scans, and bone scintigraphy, assessing detection rates, sensitivity, specificity, and changes in clinical management. Imaging interpretation occurs within one week after scan acquisition, prior to definitive treatment, with follow-up assessments up to six months. During the study, participants will have baseline and follow-up imaging tests, including chest and abdominal CT, bone scans, and PETCT scans. Researchers will evaluate how well 18F-FES PETCT detects distant and lymph node metastases, and whether it influences treatment decisions like surgery or radiotherapy planning. Patient health status and safety will be monitored throughout, with clinical management decisions reviewed up to four weeks after imaging. Total participation duration varies by individual based on follow-up needs.

CONDITIONS

Brief Title

[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer

Research Team

S

Sangwon Han

J

Jaeeun Kim

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here